Explore / Clinical trial
Clinical trial

Pilot RECAP Study in Healthy Volunteers

University of Wisconsin, MadisonCompletedPhase 1Started May 21, 20218 enrolledUnited StatesNCT04842045

Abstract

The primary objective of the RECAP Study Program is to investigate the role played by conscious experience in the antidepressant effects of the psychedelic agent psilocybin. This pilot dosing study (PILOT RECAP) is designed to determine the optimal dose of midazolam that allows a psychedelic experience to occur while inducing amnesia for the experience. This is an essential step required for subsequent evaluation of the role of memory for the psychedelic experience in the antidepressant effects of psilocybin in the full RECAP study.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Keywords

MemoryAmnesiaHealthy VolunteerPsychedelic ExperiencesAmnesia

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.